Skip to main content
Back to National Institutes of Health

National Institutes of Health's Biopharma Portfolio

Browse 6 Biopharma companies funded by National Institutes of Health. See funding amounts, founder contacts, and investment details.

Biopharma Companies
6
Total Funding in Biopharma
$43.4M

Biopharma Portfolio Companies (6)

Export
Artificial Intelligence (AI)BiopharmaBiotechnologyMedicalService Industry

Curi Bio integrates human stem cells, systems, and AI-enabled data analytics for the development of new therapeutics.

Seattle, United States
December 2025
$10.0M
Series B

Founder Contacts

19,000+ verified contacts

BiopharmaBiotechnologyHealth CareLife ScienceNeurosciencePharmaceuticalTherapeutics

Biotechnology company developing pharmaceutical therapies for nerve regeneration in the central nervous system.

San Diego, United States
January 2026
$2.5M
Grant

Founder Contacts

19,000+ verified contacts

BiopharmaBiotechnologyHealth CareLife Science

Co-Diagnostics is a molecular diagnostics company that enhances the output of molecular diagnostic tests.

Salt Lake City, United States
October 2025
$7.0M
Post Ipo Equity

Founder Contacts

19,000+ verified contacts

Biopharma

Sur180 Therapeutics is a female-led business that focuses on novel ways to treating gynecological diseases.

Mcallen, United States
July 2025
$2.4M
Grant

Founder Contacts

19,000+ verified contacts

BiopharmaBiotechnology

DIMERx operates as a biopharmaceutical company.

Orange, United States
June 2025
$15.0M
Grant

Founder Contacts

19,000+ verified contacts

BiopharmaBiotechnologyHealth CareLife ScienceMedicalNeuroscience

28bio is a neurotechnology company that develops brain-on-a-chip platform designed to capture neurological processes.

Metairie, United States
June 2025
$6.5M
Undisclosed

Founder Contacts

19,000+ verified contacts

Explore National Institutes of Health's Full Portfolio

View all companies funded by National Institutes of Health across every industry and funding stage.

View Full National Institutes of Health Portfolio